Tempest Therapeutics

TPSTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$14.648 M

$0.92 +1.58%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$26.3M

Loss-making

Shares outstanding

14,344,034

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#413ScientureSCNX$15.4M
#414VyomeHIND$15.2M
#415Tempest TherapeuticsTPST$14.6M
#416Cocrystal PharmaCOCP$14.6M
#417Kala BioKALA$14.5M

Where these numbers come from

Share counts and financials for Tempest Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.